Picture of HLB Genex logo

187420 HLB Genex Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for HLB Genex, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue18,76925,87427,80227,00835,430
Cost of Revenue
Gross Profit6,0599,83110,2157,33114,301
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses27,12129,70834,99726,51036,051
Operating Profit-8,352-3,834-7,195498-621
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-12,127-14,402-11,336-787-16,898
Provision for Income Taxes
Net Income After Taxes-12,125-8,526-13,373-722-17,933
Minority Interest
Net Income Before Extraordinary Items
Net Income-12,217-6,817-12,968-2,950-18,828
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-12,217-6,817-12,968-2,950-18,828
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-442-301-548-411-832
Dividends per Share